SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
China Botanic Pharmaceutical Inc. (CBPI) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 10/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CBPI
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.14
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2007 |
$0.27 |
$28.04M |
$9.6M |
34.2% |
| 2008 |
$0.34 |
$36.16M |
$11.98M |
33.1% |
| 2009 |
$0.41 |
$43.41M |
$14.85M |
34.2% |
| 2010 |
$0.44 |
$55.18M |
$17.87M |
32.4% |
| 2011 |
$0.69 |
$72.71M |
$25.92M |
35.6% |
| 2012 |
$-2.95 |
$0.00 |
$-109.9M |
- |
| 2013 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2020 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2021 |
$-0.01 |
$0.00 |
$-325K |
- |
| 2024 |
$-0.14 |
$0.00 |
$-2.76M |
- |
